STAAR Surgical Co. designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. These lenses provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. Co. is a manufacturer of lenses used worldwide in corrective or refractive surgery. It sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the U.S., Canada, the United Kingdom, and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux, and Italy. We show 58 historical shares outstanding datapoints in our coverage of STAA's shares outstanding history.
Understanding the changing numbers of STAA shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like STAA versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching STAA by allowing them to research STAA shares outstanding history
as well as any other stock in our coverage universe. |
Free STAA Email Alerts:
Video: Shares Outstanding Importance
